Showing results (1731-1740 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|March 24, 2022
Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumorsQi Song, Bo Yang, Wei Sheng, et al.Immunotherapy|October 15, 2019
The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditionsAlson Wai-Ming Chan, Wing Pan Luk, Ling Hiu Fung, et al.Immunotherapy|June 26, 2019
A review of kallikrein inhibitor lanadelumab in hereditary angioedemaGloria Hwang, Ansh Johri, Sally Ng, et al.Immunotherapy|July 4, 2019
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continentsDaniel Suez, Gergely Kriván, Stephen Jolles, et al.Immunotherapy|June 28, 2017
Evaluation of a new protocol for wheat desensitization in patients with wheat-induced anaphylaxisMahsa Rekabi, Saba Arshi, Mohammad Hassan Bemanian, et al.Immunotherapy|April 25, 2023
Postvaccination immune-mediated hepatitis: what do we really know?Angioletta Lasagna, Paolo Pedrazzoli, Raffaele Bruno, et al.Immunotherapy|April 25, 2023
Establishment of humanized mice and its application progress in cancer immunotherapyTianlong Ding, Yang Yu, Xiaoyuan Pan, et al.Immunotherapy|March 30, 2021
Identification and functional study of novel oligonucleotides: CpG Seq 13 and CpG Seq 19Hailing Liu, Shan Meng, Nan Yang, et al.Immunotherapy|August 12, 2020
Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell functionShuning Wei, Runxia Gu, Yingxi Xu, et al.Immunotherapy|August 11, 2020
Eculizumab in the treatment of neuromyelitis optica spectrum disorderKatrin Giglhuber, Achim BerthelePageof 190